The FirstTake Podcast – Q2 earnings kick off with yet more Aduhelm controversy

FirstTake on Pharma - Pharma News and Analysis Podcast

English - July 22, 2021 19:30 - 27 minutes - 21 MB - ★★★★★ - 2 ratings
Science pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The FirstTake Podcast – Get the expert view on new Jardiance heart failure data

Next Episode: The FirstTake Podcast – A tale of two COVID-19 vaccines

FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss the start of Q2 earnings season, including the receding impact of COVID-19 on drug sales and Biogen’s claim of a misinformation conspiracy designed to derail adoption of Aduhelm. Also under the spotlight is the HIF-PH drug class and new cardiovascular data from Cytokinetics.